Copyright
©The Author(s) 2025.
World J Stem Cells. Feb 26, 2025; 17(2): 103599
Published online Feb 26, 2025. doi: 10.4252/wjsc.v17.i2.103599
Published online Feb 26, 2025. doi: 10.4252/wjsc.v17.i2.103599
Table 2 Brief description of four clinical asthma trials related to stem cells in the clinical trials database
NCT No | Title | Disease | Source MSCs | Auto/Allo? | Delivery | Phases | Enrollment | Ages eligible for study | Locations |
02192736 | Safety and feasibility study of intranasal MTF for treatment of asthma | Asthma | UCMSC-CM | Allogeneic | Intra-nasal | 1/2 | 20 | 18-65 years old | Panama |
03137199 | Allogeneic human MSCs via intravenous delivery in patients with mild asthma | Asthma | BMSCs | Allogeneic | IV | 1 | 6 | 18-65 years old | United States |
04883320 | Stem cell strategies for the treatment of chronic asthma | Asthma | MSC | Unspecified | Not provided | Not applicable | 15 | 18-70 years old | United Kingdom |
05147688 | Safety of cultured allogeneic adult umbilical cord-derived mesenchymal stem cells for pulmonary diseases | Pulmonary diseases, asthma | UCMSC | Allogeneic | IV | 1 | 20 | Child, adult, older adult | Antigua and Barbuda |
- Citation: Chen QH, Zheng JY, Wang DC. Asthma and stem cell therapy. World J Stem Cells 2025; 17(2): 103599
- URL: https://www.wjgnet.com/1948-0210/full/v17/i2/103599.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v17.i2.103599